Duck circovirus recombinant protein and application thereof in detection of duck circovirus egg yolk antibody

By screening homologous duck cyclovirus strains and expressing recombinant Cap proteins, an efficient ELISA detection method for duck cyclovirus yolk antibodies was established, which solved the problems of long detection cycle and low sensitivity in the prior art, and achieved specificity Improvement of sexuality and sensitivity is suitable for large-scale applications.

CN119080888AInactive Publication Date: 2024-12-06SHANDONG ENOKI BIOENGINEERING CO LTD +1
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411380892.2
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-09-30
Publication Date
2024-12-06
Estimated Expiration
Not applicable · inactive patent

AI Technical Summary

Technical Problem

The prior art lacks an ELISA detection kit for yolk antibodies against duck cyclovirus, and the antigen of the ELISA detection kit on the market has not been updated, so it cannot effectively identify the mutant strain of duck cyclovirus, resulting in a long detection cycle and low sensitivity. , poor specificity.

Method used

Duck/SDENJ/04 strains that are highly homologous to the duck circovirus after 2022 in the NCBI genebank database were screened, and Cap protein was selected as the antigen, and ligated to the pET32a prokaryotic expression vector through PCR amplification and enzyme cleavage to construct a recombinant plasmid , express and purify the recombinant Cap protein of the duck cyclovirus, establish an indirect ELISA detection method, determine the optimal antigen coating concentration and sample dilution ratio, and improve the specificity and sensitivity of the detection.

Benefits of technology

A fast, high specificity and high sensitivity detection of duck circovirus yolk antibody is achieved, suitable for large-scale promotion and production, the sensitivity of the detection method is 1:12,800, and the maximum coefficient of repetitive variation in batches and between batches is 4.31%. .

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119080888A_ABST
    Figure CN119080888A_ABST
Patent Text Reader

Abstract

The invention belongs to the technical field of biology, and provides a duck circovirus recombinant protein and application thereof in detection of a duck circovirus egg yolk antibody. The amino acid sequence of the duck circovirus recombinant Cap protein is shown as SEQ ID NO: 1. The invention establishes an indirect ELISA method for rapidly detecting the duck circovirus egg yolk antibody with good specificity, sensitivity and repeatability.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the field of biotechnology, and in particular relates to a duck circovirus recombinant protein and application thereof in detecting duck circovirus yolk antibodies. Background Art

[0002] Duck circovirus is a viral infectious disease of ducks caused by infection with duck circovirus (DuCV). It was first discovered and reported in Muscovy ducks in Germany in 2003, DuCV infection was first detected in Taiwan in 2006, and DuCV was first detected in mainland my country in 2008. The virus can infect ducks of all ages and breeds, showing symptoms such as slow growth, weight loss, and decreased egg production in sick ducks, causing great economic losses to the duck industry. Duck circovirus belongs to the genus Circovirus of the family Circoviridae. According to the genetic characterization of the virus, DuCV can be divided into three genotypes: DuCV-1, DuCV-2, and DuCV-3, which contain three main open reading frames (ORFs), namely ORF1, ORF2, and ORF3. ORF1 encodes Rep protein, which is a protein essential for viral replication; ORF2 encodes Cap protein, which is the main structural protein of the virus and constitutes the nucleocapsid of the virus; ORF3 is located on the complementary chain of ORF1, and related proteins are involved in apoptosis.

[0003] Yolk antibodies are immunoglobulins extracted from immune poultry eggs that react specifically with antigens. They are currently used in the veterinary field to prevent or treat a variety of diseases. However, there are few methods for detecting yolk antibodies in poultry eggs in clinical practice. Most of them use neutralization antibody experiments or agar diffusion experiments with an experimental cycle of 3-7 days, which have problems such as long cycles, low sensitivity, and poor specificity. Enzyme-linked immunosorbent assay (ELISA for short) is a method of qualitative and quantitative detection by adsorbing known antigens or antibodies to the surface of a solid phase carrier (polystyrene microplate), adding enzyme-labeled antigens or antibodies, and reacting with antigens and antibodies to produce antigen-antibody binding reactions. The experimental process only takes 2-3 hours, and is simple to operate, low cost, and short time.

[0004] Some scholars used ORF3 of duck circovirus type 2 as an antigen to prepare an ELISA detection kit for the purpose of studying whether ORF3 of duck circovirus type 2 is deleted. However, the protein expressed by the duck circovirus ORF3 gene is still unclear, and its specific function is also unclear. The ELISA detection kit prepared using this protein as an antigen may not be able to broadly identify duck circovirus. Some scholars used the Cap protein without a nuclear localization signal of duck circovirus as an antigen to establish an indirect ELISA detection method. However, the study did not specify whether the protein sequence was synthesized based on the strain isolated in the laboratory in recent years or the sequence published on the Internet; nor did it compare the homology of the sequence with the sequences in recent years, so the broad spectrum of the kit could not be determined. There are several problems with the ELISA detection kits for duck circovirus on the market: (1) There is no ELISA detection kit for duck circovirus yolk antibodies, and there are no related literature and patent reports. (2) Duck circovirus mutates rapidly in ducks, but the antigens in the previously developed ELISA detection kits have not been updated. (3) The antigens of the duck circovirus ELISA test kit should be selected from the main immunogenic proteins and the main structural proteins. Therefore, it is urgent to develop an ELISA test kit for duck circovirus yolk antibodies. Summary of the invention

[0005] At present, the detection of duck circovirus yolk antibodies adopts neutralization antibody experiment or agar diffusion experiment, which has a long experimental cycle, low sensitivity and poor specificity. There is no ELISA detection kit for duck circovirus yolk antibodies on the market, and there is no report of relevant literature and patents. Therefore, the inventors screened out a strain of duck circovirus Duck / SDENJ / 04 / 2024, which is widely prevalent in duck farms in Shandong Province and is highly homologous to duck circovirus after 2022 in the NCBI genebank database. Using the virus as a template, according to the function of viral protein, Cap protein was selected as the antigen, and the optimal coating amount of antigen, the optimal dilution of primary antibody, the optimal dilution of secondary antibody, etc. were optimized to establish an indirect ELISA method for rapid detection of duck circovirus yolk antibodies with good specificity, sensitivity and repeatability.

[0006] In view of the problems in the prior art, the present invention provides a duck circovirus recombinant protein and application thereof in detecting duck circovirus yolk antibodies.

[0007] To achieve the above purpose, the present invention adopts the following technical solution.

[0008] (1) Four strains of viruses isolated between 2022 and 2024 were screened from the duck circovirus library of our laboratory. The virus sequences were compared with the NCBI genebank database, and the duck circovirus with the highest sequence homology with the strains after 2022 in the NCBI genebank database was screened, namely Duck / SDENJ / 04 / 2024 (abbreviated as SDENJ / 04).

[0009] (2) Genetic evolution analysis of the SDENJ / 04 strain showed that the virus belongs to the DuCV-1b subtype.

[0010] (3) Using SDENJ / 04 virus as a template, the Cap protein gene was selected and amplified by PCR. The gene was then ligated to the pET32a prokaryotic expression vector to construct the recombinant plasmid pET32a-Cap, which was then transformed into competent cells to induce the expression of the duck circovirus capsid protein Cap protein.

[0011] A duck circovirus recombinant Cap protein, whose amino acid sequence is shown in SEQ ID NO: 1.

[0012] An expression box, vector or cell capable of expressing the duck circovirus recombinant Cap protein.

[0013] A method for preparing duck circovirus recombinant Cap protein comprises the following steps: (1) synthesizing a nucleic acid having a sequence as shown in SEQ ID NO: 2; (2) Inserting the nucleic acid into the pET32a prokaryotic expression vector plasmid to obtain the recombinant prokaryotic expression plasmid pET32a-Cap; (3) Transform the recombinant plasmid into the expression competent Escherichia coli BL21 to obtain the engineered bacteria; (4) The engineered bacteria are fermented and induced to express with IPTG, and the target protein is isolated and purified.

[0014] An application of the duck circovirus recombinant Cap protein in preparing a reagent for detecting duck circovirus yolk antibodies.

[0015] The present invention has the following advantages: The established duck circovirus vaccine and egg yolk antibody indirect ELISA antibody detection method determined that the optimal antigen coating concentration was 5 μg / mL, the optimal sample dilution ratio was 1:600, the optimal secondary antibody dilution ratio was 1:30000, the positive and negative critical values ​​OD450 were 0.3823 (less than this value is negative) and 0.4129 (greater than this value is positive), the sensitivity reached 1:12800, and the intra-batch and inter-batch repeatability coefficient of variation was up to 4.31%. The detection method provided by the present invention has better specificity, sensitivity and repeatability, and is suitable for large-scale promotion and production. BRIEF DESCRIPTION OF THE DRAWINGS

[0016] Figure 1 It is the whole genome genetic evolution tree; Figure 2 It is the electrophoresis diagram for enzyme digestion verification; Figure 3 This is the SDS-PAGE electrophoresis diagram, M: protein standard molecular weight; 1: small amount of protein expression; 2: large amount of expression supernatant; 3: large amount of expression inclusion body; 4: supernatant purified protein; Figure 4 This is a WB picture, M: protein standard molecular weight; 1: Cap protein. DETAILED DESCRIPTION

[0017] The present invention is further described below with reference to the examples and drawings, but the present invention is not limited by the following examples. The various reagents mentioned in the examples but not listed are prepared according to the method of the Molecular Cloning Experiment Guide, and the biochemical reagents are analytical grade or higher.

[0018] Example 1 Screening of template viruses Four strains of viruses isolated between 2022 and 2024 were screened out from the duck circovirus library of our laboratory. The four strains were named: Duck / SDENJ / 01 / 2024, Duck / SDENJ / 02 / 2023, Duck / SDENJ / 03 / 2023, and Duck / SDENJ / 04 / 2024 (respectively abbreviated as: SDENJ / 01, SDENJ / 02, SDENJ / 03, and SDENJ / 04).

[0019] Using DNASTAR software, all DuCV full gene sequences published on NCBI GenBank before April 2024 were downloaded and genetic evolution analysis was performed with the four DuCV strains in this study. Figure 1 The results showed that these viruses all belonged to the DuCV-1b subtype. Among them, SDENJ / 04 was in a small branch of 1b. The reference strains mainly came from Cherry Valley ducks in China, and had the highest homology with duck circovirus in my country after 2022 ( Figure 1 ). Therefore, the SDENJ / 04 strain was used as a template to prepare antigens.

[0020] Example 2 Expression of Antigen 1. Amplify the target gene Primers were designed and amplified for the full-length Cap sequence of the SDENJ / 04 strain (SEQ ID NO: 3), and the nucleotide sequence of the target gene carried and expressed was as shown in SEQ ID NO: 2, with BamHI added upstream and EcoRI inserted downstream. The primers were synthesized by Sangon Biotech (Shanghai) Co., Ltd. (Table 1).

[0021] Table 1 Amplification primers 2. Construction of prokaryotic expression plasmid Using SDENJ / 04 strain DNA as template, amplification primers are shown in Table 1, and the amplification program is 94℃ 5min; 94℃ 30s, 55℃ 30s, 72℃ 45s, 34 cycles; 72℃ 10min; 4℃ maintenance, the PCR amplified fragment was identified by 1.5% agarose gel electrophoresis, the target fragment was cut and recovered, the gel recovery product was treated with DNA A-Tailing kit plus A, connected to pMD18-T, transformed into Trans5a competent cells, and plated. Bacteria were picked, shaken, and PCR was verified for bacterial solution. The positive bacterial solution was sent for sequencing. If the sequencing result was correct, the plasmid was extracted with a plasmid extraction kit. The plasmid was named pMD18T-Cap.

[0022] The above plasmid and the prokaryotic expression plasmid pET32a were digested with BamHⅠ and EcoRⅠ restriction enzymes, respectively, and the target fragment and the vector fragment were cut and recovered. The nucleic acid concentration was determined, and then the ratio was calculated according to the concentration of the vector and the plasmid. The cells were connected with T4 ligase at 16℃ overnight, transformed into Trans5a competent cells, and plated. The bacteria were picked, shaken, and the bacterial solution was PCR verified. The plasmid was extracted from the positive bacterial solution and then digested with BamHⅠ and EcoRⅠ restriction enzymes. The results are as follows: Figure 2 As shown, bands appeared at around 3000 and 774 after enzyme digestion, which was the same as expected, proving that the plasmid was successfully constructed. At the same time, the plasmid was sent for sequencing, and the sequencing results were correct. The recombinant prokaryotic expression plasmid was named pET32a-Cap.

[0023] 3. Prokaryotic plasmid protein expression and Western blot identification Transform the recombinant prokaryotic expression plasmid pET32a-Cap into BL21 expression competent cells, plate, pick a single colony and add it to 5mL LB culture medium containing ampicillin (100mg / mL) and shake at 37℃ overnight, take 2mL of bacterial solution and add it to 200mL LB culture medium containing ampicillin, shake at 37℃ for 2-3h, culture until the OD value of the bacterial solution is 0.6-0.8, add IPTG, shake at 30℃ for 6h, collect the bacterial solution and centrifuge at 4000rpm for 10min, add 20mL PBS to resuspend the bacteria and ultrasonically break them, centrifuge to separate the supernatant and precipitate (inclusion body), and dissolve the precipitate with an appropriate amount of buffer at room temperature. The inclusion body and supernatant are analyzed and identified by SDS-PAGE electrophoresis using the PAGE gel rapid preparation kit ( Figure 3). The protein was purified using the His purification kit instructions, using mouse serum prepared from duck circovirus as the primary antibody and Goat Anti-Mouse IgG (HRP) as the secondary antibody. Western blot experiments showed that the purified recombinant protein had only a single target band at 45KDa, proving that the purification effect was good ( Figure 4 ). Its amino acid sequence is shown in SEQ ID NO: 1. The concentration of the purified recombinant protein was measured by BCA protein quantification kit to be 469 μg / mL.

[0024] Example 3 Preparation of mouse polyclonal antibodies and egg yolk antibodies The mice were divided into 2 groups, 5 in each group. The first group was the whole virus immunization group, and the duck ring positive diseased material was ground and inoculated with embryo virus, and the virus was added to the adjuvant for emulsification to prepare the whole virus vaccine for immunization of mice, 0.1mL / mouse; the second group was the blank immunization group, and 0.1mL / mouse was inoculated with normal saline; immunization was performed once every 14 days, for 3 times. Blood was collected from the tail vein 7d and 14d after the 3rd immunization and stored at -20℃.

[0025] The laying hens were divided into 4 groups, 10 in each group. The first group was the blank control group, and the laying hens were injected with saline; the second group was the whole virus immunization group, and the laying hens were vaccinated with the whole virus vaccine by means of chest muscle injection; the third group was the experimental group a, and the laying hens were vaccinated with antigen protein by means of chest muscle injection, with a dose of 0.1 mg / feather; the fourth group was the experimental group b, and the laying hens were vaccinated with antigen protein by means of chest muscle injection, with a dose of 0.2 mg / feather; immunization was performed once every 10 days, for a total of 3 immunizations. Egg samples were collected 7d, 14d, 21d, and 28d after the 3 immunizations and stored at 4°C.

[0026] After cleaning the eggs, disinfect them with a chlorhexidine solution, wipe the egg shells with 75% alcohol, open the egg shells after drying, separate the egg white, extract 400 μL of egg yolk with a syringe, store it in a centrifuge tube, add 400 μL of PBS, shake to mix, add 800 μL of chloroform, shake vigorously, centrifuge at 3000 rpm / min for 15 minutes, and extract the supernatant.

[0027] Example 4 Establishment of indirect ELISA detection method The recombinant protein was diluted to 0.5, 2.5, 5, 10, 15, 20, and 25 μg / mL with carbonate buffer (Na2CO3 1.59 g / L, NaHCO3 2.93 g / L, PH = 9.6), 100 μL was added to each well, and after overnight coating at 4°C, the liquid was discarded, patted dry, and 200 μL was added to each well. 5% skim milk powder, blocked at 37℃ for 1h, discarded the liquid, washed 5 times with PBST, and patted dry; the positive samples (yolk antibodies extracted from the whole virus immunization group) and the negative samples (yolk antibodies extracted from the blank control group) were diluted 1:100, 1:200, 1:400, 1:600, 1:800, and 1:1000, respectively, and 100μL was added to each well and incubated at 37℃ for 1h; discarded the liquid, washed 5 times with PBST, and patted dry; HRP-labeled sheep anti-chicken IgY was diluted 1:10000, 1:20000, 1:30000, respectively After 1:40000, 1:50000, 1:60000, 1:70000, 1:80000, 1:90000, and 1:100000 times dilution, 100μL was added to each well and incubated at 37℃ for 1h; the liquid was discarded, PBST was washed 5 times, 100μL of TMB colorimetric solution was added to each well, color was developed in the dark for 15min, 50μL of stop solution was added to each well, OD450 value was measured, P / N value was calculated, and the group with the largest P / N value was selected to determine the optimal coating concentration of the antigen. The results showed that when the antigen coating concentration was 5μg / mL and the optimal dilution of the sample was 1:600, the maximum P / N value was 2.4490, which was the optimal concentration of antigen coating and the optimal dilution of the sample (Table 2). When the secondary antibody dilution was 1:30000, the P / N value was the largest (Table 3).

[0028] Table 2 Results of determination of optimal working concentrations of coated antigen and antibody Table 3 Determination of the optimal enzyme-labeled antibody working concentration Example 5 Determination of indirect ELISA cutoff value 25 known DuCV negative egg yolk antibodies were selected, and the samples were diluted 1:600 ​​and tested using the optimal reaction conditions determined in Example 4. The OD450 average value (x) and standard deviation (SD) were calculated. According to statistical principles, when the OD450 of the sample to be tested was ≥x+3×SD, it was judged as positive, and when the OD450 was ≤x+2×SD, it was judged as negative, and when it was between the two, it was judged as suspicious. The results showed that the average value of the 25 DuCV negative egg yolk antibodies was =0.3211, standard deviation SD=0.0306, so when the OD450 of the serum to be tested is ≥0.4129, it is judged as positive, when the OD450 of the serum to be tested is ≤0.3823, it is judged as negative, and it is suspicious when it is between the two (Table 4).

[0029] Table 4 Negative control test results Example 6 Indirect ELISA sensitivity test The positive egg yolk samples were serially diluted at 1:800, 1:1600, 1:3200, 1:6400, 1:12800, and 1:25600 times, and each dilution was used as the primary antibody for ELISA detection to determine the minimum detection titer for DuCV positive egg yolk. As shown in Table 5, the minimum detection titer of egg yolk antibodies that can be detected by this detection method can reach 12800.

[0030] Table 5 Sensitivity test of indirect ELISA method Example 7 Indirect ELISA Repeatability Test 1 Intra-batch repeatability test The ELISA plate was coated with purified protein prepared from the same batch, and three samples with different DuCV antibody levels were tested at three different time points. The test results were statistically analyzed and the coefficient of variation was calculated to determine the intra-batch repeatability of the indirect ELISA method. Four egg yolk samples (egg samples obtained at different times in Example 3) were purified from the same batch of protein and tested at three different time points. The lowest coefficient of variation was 1.28% and the highest was 4.31% (Table 6). The test results show that the indirect ELISA method has good intra-batch repeatability.

[0031] Table 6 Determination of intra-batch coefficient of variation 2. Batch repeatability test ELISA reaction plates were coated with three batches of purified antigens prepared in different batches, and three samples with different DuCV antibody levels were tested at three different time points. The test results were statistically analyzed and the coefficient of variation was calculated to determine the batch reproducibility of the indirect ELISA method. Four egg yolk samples (egg samples obtained at different times in Example 3) were purified by three batches of protein and tested at three different time points. The lowest coefficient of variation was 0.86% and the highest was 3.77% (Table 7). The test results show that the indirect ELISA method has good batch reproducibility.

[0032] Table 7 Determination of inter-batch coefficient of variation The above is only an embodiment of the present application and is not intended to limit the present application. For those skilled in the art, the present application may have various changes and variations. Any modification, equivalent replacement, improvement, etc. made within the spirit and principle of the present application should be included in the scope of the claims of the present application.

Claims

1. A duck circovirus recombinant Cap protein, characterized in that: Its amino acid sequence is shown in SEQ ID NO:

1.

2. An expression cassette, vector or cell expressing the duck circovirus recombinant Cap protein according to claim 1.

3. The expression cassette, vector or cell according to claim 2, characterized in that The recipient cell is Escherichia coli.

4. The expression cassette, vector or cell according to claim 2, characterized in that The nucleotide sequence of the target gene carried and expressed is shown in SEQ ID NO:

2.

5. A method for preparing the duck circovirus recombinant Cap protein according to claim 1, characterized in that: The following steps are involved: (1) synthesizing a nucleic acid having a sequence as shown in SEQ ID NO: 2; (2) Inserting the nucleic acid into the pET32a prokaryotic expression vector to obtain the recombinant prokaryotic expression plasmid pET32a-Cap; (3) Transform the recombinant plasmid into competent Escherichia coli BL21 to obtain engineered bacteria; (4) The engineered bacteria are fermented and induced to express with IPTG, and the target protein is isolated and purified.

6. Use of the duck circovirus recombinant Cap protein as claimed in claim 1 in preparing a reagent for detecting duck circovirus yolk antibody.